Arrowstreet Capital’s Medallia, Inc. MDLA Stock Holding History

Arrowstreet Capital’s Portfolio MDLA Stock Details MDLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-30,500	Closed	-$770K	–	2612
2020 Q2	$770K	Buy	+30,500	New	+$728K	﹤0.01%	1859
2019 Q4	–	Sell	-11,900	Closed	-$326K	–	1977
2019 Q3	$326K	Buy	+11,900	New	+$422K	﹤0.01%	1405

Other funds holding MDLA

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Arrowstreet Capital's MDLA Position: Q3 2020 in Review

Arrowstreet Capital sold out of Medallia, Inc. (MDLA) in Q3 2020, closing a stake of 30,500 shares — an estimated $770K sold.

Arrowstreet Capital first reported a position in MDLA in Q3 2019 and held it in 2 quarters. The position peaked at $770K in Q2 2020. 172 funds tracked by Wall St. Rank hold MDLA as of Q3 2020.

Arrowstreet Capital reported no remaining Medallia, Inc. position as of Q3 2020 after selling out during the quarter.
Arrowstreet Capital sold 30,500 Medallia, Inc. shares in Q3 2020, an estimated $770K.
Arrowstreet Capital first reported a position in Medallia, Inc. in Q3 2019 and held it in 2 quarters.
Arrowstreet Capital's Medallia, Inc. position peaked at $770K in Q2 2020.
172 funds tracked by Wall St. Rank held Medallia, Inc. as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.